Physician profile
Michael J Manuel
NPI 1801873641
$1,876.53
in general payments reported to CMS, 2019-2025
15 companies · $734 in 2025
The $734 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $190 · 2021: $211 · 2022: $113 · 2023: $226 · 2024: $240 · 2025: $734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884 · Education: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.73 |
| Education | $316.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $487.54 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Organogenesis INC. | $425.73 | 2019-2023 | Puraply |
| Smith+Nephew, INC. | $215.25 | 2019-2025 | Grafix Pl, Renasys Go V2 Home, Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Abbvie INC. | $159.32 | 2023-2025 | |
| Access Pro Medical, LLC | $153.43 | 2025 | Matriderm |
| Glaxosmithkline, LLC. | $124.52 | 2020 | |
| Mimedx Group, INC. | $89.97 | 2024-2025 | |
| Cashflow Solutions, LLC | $65.42 | 2023-2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Otsuka America Pharmaceutical, INC. | $43.23 | 2023-2025 | Rexulti, Nuedexta |
| Integra Lifesciences Corporation | $26.53 | 2022 | |
| Resmed Corp | $20.00 | 2021 | |
| Urgo Medical North America, LLC | $19.00 | 2025 | Urgoclean Ag |
| Polynovo North America LLC | $17.50 | 2024 | Novosorb Btm |
| Avanir Pharmaceuticals, INC. | $16.59 | 2022 | |
| Tactile Systems Technology INC | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Manuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.